BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8764249)

  • 1. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis.
    Kuwano K; Ikeda H; Oda T; Nakayama H; Koga Y; Toshima H; Imaizumi T
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1993-9. PubMed ID: 8764249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Ikeda H; Koga Y; Oda T; Kuwano K; Nakayama H; Ueno T; Toshima H; Michael LH; Entman ML
    J Am Coll Cardiol; 1994 Dec; 24(7):1749-56. PubMed ID: 7963124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
    Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
    Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
    Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation.
    Kanaya S; Ikeda H; Haramaki N; Murohara T; Imaizumi T
    Circulation; 2001 Nov; 104(20):2478-84. PubMed ID: 11705828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
    Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
    J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of a novel antiplatelet aggregating agent, E-5510, on cyclic flow variations in electrically stimulated coronary arteries of the pig.
    Adachi H; Fujimori T; Shoji T
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):733-41. PubMed ID: 1703594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans.
    Ikeda H; Koga Y; Kuwano K; Nakayama H; Ueno T; Yoshida N; Adachi K; Park IS; Toshima H
    J Am Coll Cardiol; 1993 Mar; 21(4):1008-17. PubMed ID: 8450149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation.
    Katoh A; Ikeda H; Murohara T; Haramaki N; Ito H; Imaizumi T
    Circulation; 1998 Dec 22-29; 98(25):2891-8. PubMed ID: 9860792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
    Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
    Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium.
    Charlat MI; O'Neill PG; Egan JM; Abernethy DR; Michael LH; Myers ML; Roberts R; Bolli R
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H566-77. PubMed ID: 3826401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.